Prevalence, management, and clinical consequences of QT interval prolongation during treatment with arsenic trioxide Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Arsenicals
  • Electrocardiography
  • Oxides

abstract

  • QT interval prolongation is common with ATO treatment, but clinically significant arrhythmias are rare and can be avoided with appropriate precautions. Use of the Bazett correction may result in unnecessary interruptions in ATO therapy, and alternative rate correction formulas should be considered for routine electrocardiographic monitoring.

publication date

  • November 20, 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2013.51.2913

PubMed ID

  • 25245447

Additional Document Info

start page

  • 3723

end page

  • 8

volume

  • 32

number

  • 33